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Haemophilus influenzae type b is an important cause of meningitis and other serious invasive diseases and
initiates infection by colonizing the upper respiratory tract. Among the major adhesins in H. influenzae type b
is a nonpilus protein called Hsf, a large protein that forms fiber-like structures on the bacterial surface and
shares significant sequence similarity with the nontypeable H. influenzae Hia autotransporter. In the present
study, we characterized the structure and adhesive activity of Hsf. Analysis of the predicted amino acid
sequence of Hsf revealed three regions with high-level homology to the HiaBD1 and HiaBD2 binding domains
in Hia. Based on examination of glutathione S-transferase fusion proteins corresponding to these regions, two
of the three had adhesive activity and one was nonadhesive in assays with cultured epithelial cells. Structural
modeling demonstrated that only the two regions with adhesive activity harbored an acidic binding pocket like
the binding pocket identified in the crystal structure of HiaBD1. Consistent with these results, disruption of
the acidic binding pockets in the adhesive regions eliminated adhesive activity. These studies advance our
understanding of the architecture of Hsf and the family of trimeric autotransporters and provide insight into
the structural determinants of H. influenzae type b adherence.
Haemophilus influenzae is a gram-negative coccobacillus that
causes both serious invasive disease and localized respiratory
tract disease in humans (26). Isolates of H. influenzae can be
subdivided into encapsulated and nonencapsulated forms (13).
Among encapsulated strains, six structurally and antigenically
distinct capsular types exist, designated serotypes a through f
(13). Most isolates recovered from patients with invasive dis-
ease are encapsulated and express the serotype b capsule,
while the majority of strains associated with localized disease
are nonencapsulated (nontypeable) (26).
The pathogenesis of H. influenzae type b disease begins with
colonization of the nasopharynx (26). Most type b strains are
capable of expressing hemagglutinating pili, which mediate
adherence to mucin, extracellular matrix proteins, and oropha-
ryngeal epithelial cells and facilitate the process of coloniza-
tion (6, 11, 27). Mutant strains that lack pili are also capable of
adherence and colonization, underscoring the importance of
nonpilus adhesins (6, 11, 16, 28). Based on in vitro studies with
cultured epithelial cells, the major nonpilus adhesin in H. in-
fluenzae type b is a protein called Hsf (16, 18).
Hsf is a large protein that is encoded by the hsf locus and
forms fiber-like structures on the bacterial surface (16, 18). In
H. influenzae type b strain C54, Hsf contains 2,414 amino acids
and has a predicted molecular mass of 245 kDa (18). South-
ern blot analysis has demonstrated that the hsf locus is present
in 100% of encapsulated strains tested, including representa-
tives of all six serotypes (18). Interestingly, Hsf shares signifi-
cant homology with Hia, a 1,098-amino-acid autotransporter
protein that is present in 25% of nontypeable H. influenzae
strains and mediates efficient attachment to human epithelial
cells (3, 17).
The Hia autotransporter contains three functional domains,
including an N-terminal signal peptide that targets the protein
to the inner membrane, a C-terminal translocator domain that
forms a trimer in the outer membrane, and an internal pas-
senger domain that is presented on the bacterial surface via the
C-terminal translocator domain (8). The passenger domain of
Hia has been shown to possess two distinct binding domains,
referred to as HiaBD1 and HiaBD2. These two domains bind
to the same host cell receptor, although with differing affinities
(10). Based on examination of glutathione S-transferase (GST)
fusion proteins in assays with Chang epithelial cells, HiaBD1
has a Kd of 0.05 to 0.1 nM and HiaBD2 has a Kd of 1 to 2 nM.
In recent work, we solved the crystal structure of HiaBD1 and
discovered that the domain is an intricately folded trimer with
three identical acidic binding pockets, one on each face of the
trimer (29).
In this study, we report that Hsf contains three regions with
high-level homology to the binding domains in Hia. Based on
assays with GST fusion proteins and Chang epithelial cells, two
of the three homologous regions possess adhesive activity and
the third is nonadhesive. Structural modeling revealed that
only the two regions with adhesive activity harbor an acidic
binding pocket like the binding pocket in HiaBD1. Interest-
ingly, disruption of the binding pockets in the two adhesive
regions abrogated adhesive activity. These results provide im-
portant insights into the mechanism of Hsf-mediated adher-
ence and the determinants of H. influenzae type b colonization.
* Corresponding author. Mailing address: Duke University Medical
Center, Box 3352, Durham, NC 27710. Phone: (919) 681-4080. Fax:
(919) 681-2714. E-mail: j.stgeme@duke.edu.
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Bacterial strains, plasmids, and culture conditions. Escherichia coli DH5
(Life Technologies) and E. coli BL21(DE3) are laboratory strains that have been
described previously (22). Encapsulated H. influenzae type b strain C54 is the
strain from which hsf was originally cloned, and nontypeable H. influenzae strain
11 is the strain from which hia was originally cloned (3). H. influenzae type b
strain Eagan is a clinical isolate from a child with meningitis and has been
described previously (1).
The plasmid pDC601 contains hsf from H. influenzae strain C54 cloned into
pT7-7, and the plasmid pHMW8-7 contains hia from H. influenzae strain 11
cloned into pT7-7 (3, 18).
The plasmid pNS1 encodes the Hia signal peptide (amino acids 1 to 49) fused
to the Hia translocator domain (amino acids 977 to 1098). To generate this
plasmid, first the hia promoter and coding sequence for the Hia signal peptide
were cloned into the HindIII site in pHAT10 (Clontech). The resulting plasmid
was digested with SacI and EcoRI and ligated to a SacI-EcoRI fragment con-
taining coding sequence for the Hia translocator domain. A partial multiple
cloning site remained between the coding sequence for the signal peptide and the
coding sequence for the translocator domain, allowing insertion of other DNA
fragments.
To generate pNS1/HsfBD1, DNA corresponding to residues 1899 to 2032 of
Hsf was amplified by PCR from pDC601, engineering BamHI and KpnI sites at
the 5 and 3 ends, respectively. The resulting fragment was digested with BamHI
and KpnI and then ligated into BamHI-KpnI-digested pNS1. To generate pNS1/
HsfBD2 and pNS1/HsfBD3, DNA corresponding to Hsf residues 532 to 664
(HsfBD2) and 1209 to 1347 (HsfBD3) was amplified by PCR from pDC601,
engineering SalI and BamHI sites at the 5 and 3 ends, respectively. The
resulting fragments were digested with SalI and BamHI and then ligated into
SalI-BamHI-digested pNS1. The primers used to generate pNS1/HsfBD1, pNS1/
HsfBD2, and pNS1/HsfBD2 are listed in Table 1.
E. coli strains were grown on Luria-Bertani (LB) agar or in LB broth and were
stored at 80°C in LB broth with 30% glycerol. H. influenzae was grown on
chocolate agar and was stored at 80°C in brain heart infusion broth with 20%
glycerol. Plasmids were selected with 100 g/ml ampicillin.
Recombinant DNA methods. DNA ligations, restriction endonuclease diges-
tions, gel electrophoresis, and PCR were performed according to standard tech-
niques (15). Plasmids were introduced into E. coli by electroporation (2).
Site-directed mutagenesis reactions were performed using standard protocols
and the QuikChange site-directed mutagenesis kit (Stratagene). Mutagenized
plasmids were transformed initially into E. coli XL-1 Blue, and nucleotide se-
quencing was performed. Plasmid clones with the correct nucleotide sequence
were then transformed into E. coli DH5 or E. coli BL21(DE3).
Construction of GST fusion proteins. Constructs for the expression of GST
fusion proteins were generated using the vector pGEX-6P-1 (Amersham Phar-
macia Biotech). Relevant fragments of DNA were amplified by PCR using
primers based on the hsf sequence from H. influenzae strain C54. Primers were
engineered to introduce a BamHI site at the 5 end of each fragment and a stop
codon followed by an EcoRI site at the 3 end of each fragment. PCR products
were digested with BamHI and EcoRI and then ligated into pGEX-6P-1. GST-
HsfBD1 encodes Hsf residues 1860 to 2080, GST-HsfBD2 encodes Hsf residues
537 to 738, and GST-HsfBD3 encodes Hsf residues 1169 to 1347.
Purification of GST fusion proteins. In order to purify GST fusion proteins,
pGEX-6P-1 derivatives were introduced into E. coli BL21(DE3). The resulting
strains were grown at 37°C in 250 ml of LB medium containing 100 g/ml
ampicillin to an optical density at 600 nm of 0.5. Subsequently, isopropyl--D-
thiogalactopyranoside (IPTG) was added to achieve a final concentration of 0.1
mM, and the cultures were incubated for an additional 5 h at 30°C. Bacteria were
harvested by centrifugation at 6,600 g and were then resuspended in 25 ml lysis
buffer (5 mM EDTA, 1 mM Pefabloc SC, 1:100 protease inhibitor mix [Roche
Molecular Biochemicals] in phosphate-buffered saline [PBS]) and lysed by pass-
ing them through a French pressure cell two times. Cell fragments were removed
by centrifugation at 10,000  g, Triton X-100 was added to a final concentration
of 1%, and GST fusion proteins were isolated by affinity chromatography using
glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech). Following ex-
tensive washing with PBS, fusion proteins were eluted with elution buffer (25 mM
glutathione,100 mM NaCl, 50 mM Tris-HCl, pH 8.0). Alternatively, the Hsf
portion was cleaved from GST by adding 80 U/ml PreScission protease (Amer-
sham Pharmacia Biotech) and 1 mM dithiothreitol to the beads and incubating
them overnight at 4°C. Isolated proteins were stored in 10% glycerol at 80°C
and were analyzed for purity by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis and staining with Coomassie blue.
Cell fractionation and protein analysis. Outer membrane proteins were re-
covered on the basis of Sarkosyl insolubility and were denatured with 95% formic
acid as described previously (4, 21). Proteins were then resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and were transferred to ni-
trocellulose membranes. Western blots were performed with a guinea pig poly-
clonal antiserum raised against Hsf residues 174 to 608 and a secondary anti-
guinea pig immunoglobulin G antiserum conjugated to horseradish peroxidase
(Sigma). Proteins were visualized by incubation with a chemiluminescent sub-
strate solution (Pierce) and exposure to film.
Detection of protein binding by immunofluorescence. Chang epithelial cells
(Wong-Kilbourne derivative, clone 1-5c-4, human conjunctiva; ATCC CCL20.2)
were seeded at a density of 8  104 per well onto glass coverslips in 24-well tissue
culture plates, and the plates were then incubated overnight. After being washed
with PBS, the cells were fixed for 15 min with 2.5% (vol/vol) paraformaldehyde–
0.2% (vol/vol) glutaraldehyde in PBS. Subsequently, the monolayers were
washed once with PBS and treated with 20 mM ethanolamine in PBS. After
being blocked with 3% bovine serum albumin in PBS for 30 min, the cell
monolayers were incubated for 1 h with 100 nM of the relevant purified GST
fusion protein, and protein binding was detected using an anti-GST antibody
(Amersham Pharmacia Biotech; 2 g/ml) and a Cy2-conjugated secondary an-
tibody (Jackson ImmunoResearch; 1:200). Samples were mounted in Moviol/
DABCO and were analyzed by immunofluorescence microscopy.
Quantitation of protein binding by cellular ELISA. ELISAs were performed
as described previously (10). Briefly, Chang cells were seeded at a density of 1.8
 105 per well in 96-well tissue culture plates and were incubated overnight to
approximately 90 to 100% confluence. After the monolayers were fixed and
nonspecific binding sites were blocked, the relevant protein was added and
incubated for 2 h at 37°C. The monolayers were then washed four times with PBS
and incubated with an antibody against GST and a horseradish peroxidase-
conjugated secondary antibody. Protein binding was quantitated with an ABTS
[2,2-azinobis(3-ethylbenzthiazolinesulfonic acid)] substrate solution (Roche) by
measuring absorbance at 405 nm in a microplate reader (Bio-Tek Instruments).
Kd values were determined using GraphPad Prism software. Experiments were
performed in triplicate on at least three occasions.
Quantitative adherence assays. Adherence assays were performed as de-
scribed previously (19, 20). Briefly, bacteria were inoculated into broth culture
from LB-ampicillin plates and allowed to grow to a density of 109 CFU per ml.
Approximately 1  107 to 2  107 CFU were inoculated onto confluent Chang
cell monolayers in 24-well plates, and the plates were centrifuged at 165  g for
5 min. After incubation at 37°C in 5% CO2 for 25 min, the monolayers were
rinsed four times with PBS to remove nonadherent bacteria. Trypsin-EDTA was
added to the monolayers, and dilutions were plated on agar to yield the number
of adherent CFU per monolayer. Adherence was calculated by dividing the
number of adherent CFU per monolayer by the number of inoculated CFU per
monolayer.
For adherence inhibition assays, monolayers were preincubated with 100 nM
of purified protein, from which the GST moiety had been cleaved, for 1.5 h at
37°C in 5% CO2. The monolayers were then rinsed twice with PBS to remove
unbound protein. At this point, bacteria were inoculated, and adherence was
measured as described above.
Sequencing of the hsf gene from H. influenzae strain Eagan. The hsf gene from
H. influenzae strain Eagan was amplified by PCR using genomic DNA as a
template and platinum Pfx polymerase (Invitrogen). PCR primers were con-
structed corresponding to the regions just 5 and 3 to the coding region of strain
C54 hsf, with engineered EcoRI and BamHI sites, respectively. The resulting
TABLE 1. Nucleotide primer sequences for generation of pNS1/
HsfBD1, pNS1/HsfBD2, and pNS1/HsfBD3
Plasmid Primers
pNS1/HsfBD1.........5 primer: 5 GCAGGATCCATTAGCGCGGGTAATAA
AG
3 primer: 5 GCAGGTACCTTCATTCGATTTAACCAC
pNS1/HsfBD2.........5 primer: 5 GCAGTCGACATTAAAGCAGGTAATAA
AGC
3 primer: 5 GCAGGATCCTTCAAGACCGCAATCCGC
pNS1/HsfBD3.........5 primer: 5 GAAGTCGACATTAGTGCGGGTAATAAA
GAA
3 primer: 5 GAAGGATCCTTCAAGACCATCACCAAC
TTTGGC
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product was gel purified, digested, and ligated into EcoRI-BamHI-digested
pT7-7. The entire insert was then sequenced with 2 coverage and assembled
using the ContigExpress program (Vector NTI).
Nucleotide sequencing and DNA and protein sequence analyses. Nucleotide
sequencing was performed using an ABI automated sequencer and the Big Dye
Terminator Premix-20 kit version 3.1 (Applied Biosystems–Perkin-Elmer), with
double-stranded plasmid DNA as a template. DNA sequence analysis was per-
formed using the Genetics Computer Group software package from the Univer-
sity of Wisconsin (Wisconsin Package version 10; Genetics Computer Group,
Madison, WI). Amino acid sequence alignments were performed using BLAST
at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih
.gov/BLAST/) and ClustalW at EBI (http://www.ebi.ac.uk/clustalw/).
Sequence alignments and molecular modeling. The amino acid sequence of
the HiaBD1 binding domain (Hia residues 586 to 705) was aligned with the
homologous sequences in Hsf (HsfBD1, residues 1904 to 2022; HsfBD2, residues
537 to 653; and HsfBD3, residues 1214 to 1338). The pairwise sequence align-
ments of HiaBD1-HsfBD1, HiaBD1-HsfBD2, and HiaBD1-HsfBD3 were gen-
erated using the ClustalW program and SWISS-MODEL (Automated Protein
Modeling Server) (7, 25). The basic pairwise alignment of each set is identical to
the multiple sequence alignment of HiaBD1. Homology models of the HsfBD1,
HsfBD2, and HsfBD3 subunits were built using the MODELER module avail-
able in the INSIGHTII software (Accelrys Inc., San Diego, CA) and on the
SWISS-MODEL server. To generate homotrimers, the structures of the three
subunits were superimposed onto the crystal structure of the HiaBD1 trimer
using graphic program O (9). The final models generated after energy minimi-
zation were evaluated for stereochemical quality using the validation program
PROCHECK. Ramachandran plots of the model structures indicated that over
96% of residues were in allowed regions, with no disallowed regions.
Nucleotide sequence accession number. The accession number for the strain
Eagan hsf gene sequence is AY823627.
FIG. 1. Schematic representation of Hsf similarity to Hia in regions of functional significance. The signal peptide of each protein is depicted
in black and labeled SP. The Hia minimal translocation domain is represented in black with white stripes. The two binding domains of Hia are
represented as white boxes and are labeled BD1 and BD2, respectively. The amino acid residues defining the boundaries of these regions are listed
above each of them. The C terminus of Hsf is represented in black with white stripes to indicate its absolute identity to the Hia minimal translocator
domain. Three regions of Hsf share homology with the Hia binding domains and are represented with white boxes. These have been labeled BD1,
BD2, and BD3.
FIG. 2. Binding by GST-Hsf fusion proteins to Chang epithelial cells, assessed by immunofluorescence microscopy. GST alone (A), GST-
HsfBD1 (B), GST-HsfBD2 (C), and GST-HsfBD3 (D) were incubated with fixed Chang epithelial cells for 90 min. After the cells were washed,
bound protein was visualized using an antiserum against GST and a Cy2-conjugated secondary antibody. Exposure times were identical for all
samples.
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Hsf has a conserved architecture and high similarity to Hia
in regions of functional significance. In earlier work, we fo-
cused on the Hsf protein expressed by H. influenzae type b
strain C54. To expand our understanding of the functional
domains of Hsf, we began by cloning and sequencing the hsf
gene from H. influenzae strain Eagan, a serotype b strain that
belongs to one of the two most common clonal groups impli-
cated in invasive disease (12). The resulting gene was found to
contain 7,242 nucleotides, encoding a protein with 2,414 amino
acids and a predicted molecular mass of 245 kDa. The pre-
dicted amino acid sequence of HsfEagan is virtually identical to
the predicted sequence of HsfC54, with only four divergent
amino acids.
As shown schematically in Fig. 1, comparison of the amino
acid sequences of HsfC54, HsfEagan, and Hia11 revealed several
notable features. In particular, the Hsf and Hia proteins share
absolute identity over the final 76 amino acids, a region found
previously to represent the minimal translocator domain in Hia
(necessary for presentation of the Hia passenger domain on
the bacterial surface) (24). In addition, residues 1904 to 2022 at
the C-terminal end of Hsf share 71% identity and 89% simi-
larity with the HiaBD1 domain and 44% identity and 80%
similarity with the HiaBD2 domain, residues 537 to 652 near
the N-terminal end of Hsf share 49% identity and 87% simi-
larity with HiaBD1 and 63% identity and 89% similarity with
HiaBD2, and residues 1214 to 1338 in the middle of Hsf share
41% identity and 73% similarity with HiaBD1 and 35% iden-
tity and 69% similarity with HiaBD2. Based on the relative
levels of homology to HiaBD1 and HiaBD2, we refer to these
regions as HsfBD1 (residues 1904 to 2022), HsfBD2 (residues
537 to 652), and HsfBD3 (residues1214 to 1338), respectively.
Hsf contains two binding pockets with differing binding
affinities. Given the homology between HsfBD1, HsfBD2, and
HsfBD3 and the HiaBD1 and HiaBD2 binding domains, we
examined the adhesive activities of the HsfBD1, HsfBD2, and
HsfBD3 regions in assays with Chang conjunctival cells. As a
first step, we generated GST fusion proteins containing
HsfBD1 (GST-HsfBD1), HsfBD2 (GST-HsfBD2), and
HsfBD3 (GST-HsfBD3). Following purification of these pro-
teins, 100 nM quantities were incubated with epithelial cell
monolayers, and binding was assessed by immunofluorescence
microscopy using an antiserum against GST and a Cy2 second-
ary antibody. As shown in Fig. 2, GST-HsfBD1 demonstrated
strong punctate fluorescence, GST-HsfBD2 demonstrated low-
intensity punctate fluorescence, and GST-HsfBD3 demon-
strated only background fluorescence (indistinguishable from
GST alone).
To extend these results, we examined the ability of 100 nM
of the purified fusion proteins to inhibit adherence by E. coli
expressing wild-type Hsf. As shown in Fig. 3, preincubation of
Chang epithelial cell monolayers with HsfBD1 almost com-
pletely blocked bacterial Hsf-mediated adherence. In contrast,
preincubation with HsfBD2 resulted in only a partial block of
adherence, and preincubation with HsfBD3 had no effect on
adherence, consistent with our findings using immunofluores-
cence microscopy.
Given the differences in adhesive activity of the HsfBD1 and
HsfBD2 regions as assessed by immunofluorescence micros-
FIG. 3. Inhibition of Hsf-mediated bacterial adherence by purified
HsfBD1, HsfBD2, and HsfBD3. Chang epithelial cells were preincu-
bated for 90 min with 100 nM of purified HsfBD1, HsfBD2, or
HsfBD3. After the cells were washed to remove unbound protein,1.5
 107 CFU of BL21(DE3)/pDC601, expressing full-length Hsf, were
inoculated onto the monolayers, and adherence was measured in a
standard 30-minute adherence assay. Adherence values were normal-
ized to adherence by BL21(DE3)/pDC601 to monolayers that were not
pretreated with purified protein (no protein; defined as 100%). The
absolute level of adherence by BL21(DE3)/pDC601 by itself was ap-
proximately 107 CFU per monolayer. The bars represent means plus
standard errors of three measurements from a representative experi-
ment.
FIG. 4. Determination of relative binding of the functional Hsf
binding domains. GST-HsfBD1, GST-HsfBD2, and GST alone were
added to Chang epithelial cell monolayers and incubated for 2 h. After
unbound protein was washed off, binding was measured by ELISA
using an antibody against GST and a horseradish peroxidase-conju-
gated secondary antibody. Abs, absorbance. The error bars indicate
standard deviations.
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FIG. 5. Homology modeling of the Hsf binding domains. (A) Sequence alignment of HiaBD1 (residues 586 to 705) with homologous regions in Hsf.
Residues that are identical in all sequences are highlighted in orange, and residues that are conserved in all sequences are highlighted in yellow. Residues
that are identical to the HiaBD1 sequence are indicated with green boxes. Essential amino acids in the binding pocket of HiaBD1 are indicated with red
boxes. The previously annotated secondary structural elements of HiaBD1 are shown at the top of the sequence alignment, with  strands and helices
indicated as arrows and cylinders, respectively. D2 and D3 indicate domain 2 and domain 3 of HiaBD1. (B) Ribbon diagrams of crystal structure of
HiaBD1 and homology-modeled structures of HsfBD1, HsfBD2, and HsfBD3. Domain 2 and domain 3 (defined in panel A) of HiaBD1 are colored in
green and blue, respectively. Each subunit of the HiaBD1 trimer is colored in a different shade of green or blue. In the modeled structures of HsfBD1,
HsfBD2, and HsfBD3, the subunits of the trimer are colored in silver, gray, and black, and nonconserved residues between HiaBD1 and HsfBD1, between
HiaBD1 and HsfBD2, and between HiaBD1 and HiaBD2 are color coded in red, blue, and yellow, respectively. Previously identified active-site residues
in HiaBD1 and corresponding residues in HsfBD1, HsfBD2, and HsfBD3 are shown in ball-and-stick representation. (C) Close-up views of the active
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copy and adherence inhibition, we evaluated binding affinities
using a cell-based ELISA. GST fusion proteins were added to
Chang epithelial cell monolayers in 96-well plates at concen-
trations ranging from 6 pM to 100 nM, and binding was de-
tected using anti-GST antiserum. As shown in Fig. 4, GST-
HsfBD1 bound with high affinity, with a Kd of 0.2 nM. GST-
HsfBD2 bound with significantly lower affinity, with a Kd of
2.5 nM. This 10-fold difference in affinity was observed in
multiple experiments and is similar to the difference detected
between HiaBD1 and HiaBD2 in Hia (10).
Homology modeling of HsfBD1, HsfBD2, and HsfBD3. To
begin to elucidate why HsfBD1 and HsfBD2 are adhesive and
HsfBD3 is nonadhesive, we generated model structures of the
three domains, using the crystal structure of HiaBD1 (PDB
code, 1S7 M), which was solved at 2.1 Å. In previous work, we
demonstrated that domains D2 and D3 of each subunit of
HiaBD1 (D2 and D3 in Fig. 5A) form an acidic binding pocket,
resulting in three independent binding sites on the surface of
the HiaBD1 trimer. The core of the acidic binding pocket is
defined by HiaBD1 residues D618, A620, and V656. As shown
in the multiple sequence alignment depicted in Fig. 5A, the
secondary structural elements observed in HiaBD1 are well
conserved in HsfBD1, HsfBD2, and HsfBD3. In addition, the
crystal structure of HiaBD1 and the model structures of
HsfBD1, HsfBD2, and HsfBD3 possess the same fold and
trimer assembly (Fig. 5B). The HiaBD1 structure and the
HsfBD1 structure are most similar, and the residues essential
for HiaBD1 binding activity (D618, A620, and V656) are
strictly conserved in the HsfBD1 model structure (D1935,
A1937, and V1972), creating an analogous binding pocket. The
residues essential for HiaBD1 binding activity are also con-
served in the HsfBD2 model structure (E569, A571, and
V606), again creating an analogous binding pocket. In con-
trast, the HsfBD3 model structure lacks an acidic binding
pocket, containing K1247 and D1249 at the residues that cor-
respond to D618 and A620 in HiaBD1. Closer examination
revealed that the basic K1247 residue in HsfBD3 spans the
pocket and creates a surface that differs significantly from the
acidic binding pocket in HiaBD1.
HsfBD1 and HsfBD2 mediate adherence to epithelial cells
via an acidic pocket similar to the pocket in HiaBD1. To
validate the HsfBD1, HsfBD2, and HsfBD3 model structures
and establish the structural determinants of Hsf adhesive ac-
tivity, we began by expressing HsfBD1, HsfBD2, or HsfBD3
individually on the surface of E. coli. Our approach involved
generation of chimeric proteins with HsfBD1, HsfBD2, or
HsfBD3 inserted between the Hia signal peptide (amino acids
1 to 49) and the Hia translocator domain (amino acids 977 to
1098), allowing surface presentation of the relevant Hsf do-
main. Western analysis of the resulting E. coli strains estab-
lished that the chimeric proteins were localized in the outer
membrane in comparable amounts (data not shown). As
shown in Fig. 6, E. coli/HsfBD1 and E. coli/HsfBD2 exhibited
high-level adherence to cultured epithelial cells, while E. coli/
HsfBD3 was nonadherent.
To assess the importance of the acidic pockets in HsfBD1
and HsfBD2, we mutated D1935 in the HsfBD1 chimeric pro-
tein and E569 in the HsfBD2 chimeric protein to alanine
residues. Examination of outer membrane fractions from the
resulting recombinant strains revealed that the mutated pro-
teins were localized to the outer membrane and were present
at wild-type levels (data not shown). Similar to previous ob-
servations with the D618A mutation in HiaBD1, mutation of
D1935 and E569 completely eliminated adhesive activity (Fig.
6) in assays with Chang epithelial cells, arguing that HiaBD1,
HsfBD1, and HsfBD2 bind to epithelial cells via a common
acidic patch.
To examine the interrelationship between the HsfBD1 and
HsfBD2 binding domains, we introduced the E569A and the
D1935A point mutations individually and in combination in
full-length Hsf and then expressed the resulting proteins in E.
coli. As shown in Fig. 7A, the point mutations had no effect on
the amount of Hsf present in the bacterial outer membrane.
Consistent with the high-level adherence mediated by the
HsfBD1 and HsfBD2 domains in isolation, neither the E569A
mutation by itself nor the D1935A mutation by itself had any
effect on adherence (Fig. 7B). However, the E569A and the
D1935A mutations in combination completely eliminated Hsf-
mediated adherence (Fig. 7B).
Considered together, these findings indicate that HsfBD1
and HsfBD2 contribute independently to Hsf-mediated adher-
ence to Chang epithelial cells and provide further evidence
that HsfBD3 lacks adhesive activity.
DISCUSSION
In this study, we examined the architecture and adhesive
activity of the H. influenzae type b Hsf adhesin. Alignment of
the predicted amino acid sequences of Hsf proteins from two
different type b strains and the Hia protein from a prototype
FIG. 6. Adherence by Hsf binding domains expressed individually
as chimeric proteins in E. coli strain DH5. DH5/HsfBD1, DH5/
HsfBD2, and DH5/HsfBD3 were inoculated onto Chang epithelial
cell monolayers and incubated for 30 min at 37°C. After the monolay-
ers were rinsed to remove unbound bacteria, adherent bacteria were
quantitated. Adherence is plotted as a percentage of the bacterial
inoculum that bound to the epithelial cell monolayer. HsfBD1-
D1936A is identical to HsfBD1 except that it contains an aspartic
acid-to-alanine mutation at residue 1936. HsfBD2-E569A is equivalent
to HsfBD2 except that it contains a glutamic acid-to-alanine mutation
at residue 569. The error bars indicate standard deviations.
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nontypeable strain revealed absolute identity over the C-ter-
minal 76 amino acids. In earlier work on Hia, we established
that this region harbors translocator activity and defines the
subfamily of trimeric autotransporters (24, 29). Accordingly,
we conclude that Hsf is a trimeric autotransporter protein.
Upon closer examination of the alignment of Hsf and Hia
sequences, we observed that three distinct regions in the Hsf
passenger domain share striking homology with the HiaBD1
and HiaBD2 binding domains in Hia. Further analysis estab-
lished that two of the three homologous regions harbor adhe-
sive activity and possess an acidic binding pocket like the bind-
ing pocket identified in the crystal structure of HiaBD1. Based
on experiments using purified protein, these two regions have
distinct binding affinities that differ by approximately 10-fold,
analogous to the HiaBD1 and HiaBD2 binding domains. As
with Hia, the higher-affinity Hsf adhesive region (HsfBD1) is
located near the C terminus of the passenger domain and the
lower-affinity adhesive region (HsfBD2) is located near the N
terminus of the passenger domain. In this context, it is inter-
esting that the higher-affinity Hsf adhesive region is most sim-
ilar to HiaBD1 and the lower-affinity Hsf adhesive region is
most similar to HiaBD2, based on comparison of primary
amino acid sequences.
Given that Hsf is anchored in the outer membrane by its
C-terminal translocator domain and forms a fiber on the bac-
terial surface, it is likely that HsfBD2 is situated away from the
bacterial cell wall, at the distal end of the fiber. This arrange-
ment raises the possibility that Hsf-mediated adherence to host
cells is a two-step process that exploits the different binding
affinities of HsfBD1 and HsfBD2. In particular, the lower-
affinity HsfBD2 domain may make initial contact with the host
cell and may then be displaced by the higher-affinity HsfBD1
domain, resulting in a ratcheting effect that pulls the bacterium
closer to the host cell surface. This ratcheting effect may be
especially important in an encapsulated organism, where the
polysaccharide capsule may mask HsfBD1 and make it rela-
tively inaccessible to the host cell. According to this model, the
lower-affinity binding domain must be responsible for the ini-
tial interaction with the receptor and hence must be located at
the distal end of the Hsf fiber, allowing competitive displace-
ment by the higher-affinity binding domain. If instead the high-
er-affinity binding domain were located at the tip of the fiber
and responsible for initial contact, competitive displacement
would not occur and intimate adherence would be hindered.
As another model for Hsf-mediated interaction with host
cells, it is possible that HsfBD1 and HsfBD2 engage in a
FIG. 7. Effects of binding domain point mutations on bacterial adherence mediated by full-length Hsf. (A) Outer membrane fractions were
isolated from E. coli BL21(DE3) expressing wild-type or mutant Hsf, and Hsf was detected by Western analysis. (B) Adherence to Chang epithelial
cell monolayers by E. coli BL21(DE3) expressing wild-type or mutant Hsf was measured in quantitative assays. Adherence values were normalized
to adherence by BL21(DE3) expressing wild-type Hsf, defined as 100%. The bars represent means plus standard errors of three measurements
from a representative experiment.
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bivalent interaction independent of their relative locations
within the Hsf fiber. The HsfBD1 and HsfBD2 binding do-
mains in a single Hsf fiber may bind to two separate receptor
molecules or to homologous domains on the same receptor,
increasing the avidity of the interaction with the host cell sur-
face and stabilizing adherence despite significant physical
forces in the respiratory tract, including the mucociliary esca-
lator, coughing, and sneezing. Of note, there are several eu-
karyotic cell adhesion molecules that mediate cell-cell contact
via multiple binding domains and multivalent interactions with
the same target molecule. Examples include neural cell adhe-
sion molecule, PECAM-1, and cadherins (5, 14, 23).
We found that HsfBD1 and HsfBD2 demonstrated different
binding affinities when assessed by ELISA using purified GST
fusion proteins but mediated similar levels of bacterial adher-
ence when expressed on the surfaces of bacteria either as
chimeric proteins or in the context of full-length Hsf. In con-
sidering this apparent inconsistency, we propose that the pres-
ence of multiple subunits on the surface of a single bacterium
provides a compensatory effect that allows proteins with de-
creased affinity to mediate full-level adherence within our as-
say. Indeed, previous experiments mapping the adhesive
pocket within HiaBD1 support this point. In particular, iso-
lated mutations of N617, E668, and E678 resulted in a marked
decrease in the adhesive function of GST-HiaBD1 but had no
effect on adherence when present in Hia expressed on the
surfaces of bacterial cells (29). Of note, our in vitro adherence
assay lacks the shear forces and other variables present during
natural infection, potentially precluding appreciation of the
different affinities of HsfBD1 and HsfBD2.
The overall similarities between the HiaBD1 crystal struc-
ture and the HsfBD1 and HsfBD2 model structures raised the
possibility that these domains interact with epithelial cells by a
conserved mechanism. Consistent with this possibility, the
acidic binding pocket in HiaBD1 is present in HsfBD1 and
HsfBD2 as well. Furthermore, individual point mutations dis-
rupting this pocket in HsfBD1 and HsfBD2 completely abro-
gated the adhesive function. Considered together, these obser-
vations argue strongly that Hia and Hsf interact with the same
host cell receptor and that encapsulated and nonencapsulated
strains of H. influenzae may compete with each other for ad-
hesive surfaces in the respiratory tract. With this information
in mind, it is likely that compounds designed to prevent Hsf-
mediated colonization by encapsulated H. influenzae would
also block colonization by a significant fraction of nontypeable
H. influenzae strains.
In Hsf, the sequence between the HsfBD1 and HsfBD2
binding domains is 1,252 amino acids in length, approximately
three times longer than the sequence between the HiaBD1 and
HiaBD2 binding domains in Hia (406 amino acids). The length
of the intervening sequence in Hsf may be critical to extend
HsfBD2 beyond the polysaccharide capsule and allow adher-
ence in the presence of encapsulation. Interestingly, the inter-
vening sequence in Hsf contains the HsfBD3 domain, which
shares significant homology with HiaBD1 but lacks the acidic
binding pocket critical for adhesive activity in HiaBD1,
HsfBD1, and HsfBD2. Closer examination of the alignment of
HsfBD3 and HiaBD1 reveals that sequence homology is high-
est over the C-terminal halves of the sequences, corresponding
to the region designated domain 3 in HiaBD1. Domain 3
contains extensive interdigitation of  strands from the three
subunits in the trimer and is believed to play an important role
in stabilizing the trimeric structure (29). Accordingly, it is pos-
sible that HsfBD3 evolved to serve a structural role, stabilizing
the long intervening sequence in Hsf and facilitating accessi-
bility of HsfBD2 to host cell receptors. It is also possible that
HsfBD3 mediates adherence to different cell types by a differ-
ent mechanism, independent of an acidic binding pocket.
In summary, our results establish that the H. influenzae type
b Hsf adhesin has two binding domains, namely, the HsfBD1
domain located adjacent to the bacterial cell wall and the
HsfBD2 domain, which appears to be located near the tip of
the Hsf fiber. Both HsfBD1 and HsfBD2 share significant
homology with the HiaBD1 high-affinity binding domain in Hia
and mediate adherence via a conserved acidic binding pocket.
The HsfBD3 domain also shares similarity with HiaBD1 but
lacks the acidic binding pocket and lacks adhesive activity in
assays with Chang epithelial cells. We propose that HsfBD3
may play an important structural role, stabilizing the Hsf fiber
and facilitating Hsf-mediated adherence in the context of a
polysaccharide capsule.
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